Statins have been demonstrated to be beneficial for secondary prevention of cardiovascular
(CV) events also in the elderly. However, a great debate is ongoing about the actual …

In the much older population (≥ 80 years), the management of cardiovascular diseases
requires specific research to avoid a plain transposition of medical practice from younger …

Objective: The objective is to review the evidence evaluating the efficacy of statin therapy for
primary prevention of cardiovascular (CV) disease in the elderly. Data Sources: A literature …

Background The risk/benefit ratio of using statins for primary prevention of cardiovascular
(CV) events in elderly people has not been established. The main objectives of the present …

BACKGROUND:: Although statins have been demonstrated to be beneficial for secondary
prevention in the elderly, their use for primary prevention has not been well described …

The elderly population is increasing worldwide, with subjects> 65 years of age constituting
the fastest-growing age group. Furthermore, the elderly face the greatest risk and burden of …

Background. Cardiovascular disease is the principal cause of mortality in older individuals,
and more than 80% of deaths due to coronary heart disease or stroke occur in patients over …

Cardiovascular disease (CVD) is the leading cause of death, with a higher prevalence in
older adults who form an increasing proportion of the population of the United States. Statin …

Abstract Purpose of Review Our aim was to examine the current evidence behind
prescribing statins to individuals over 65 years of age with emphasis on those older than 75 …

Method Methodic review of large randomized clinical trials and meta-analyzes that included
patients 75 years and older treated with statins in primary prevention. Results Since the …